...
首页> 外文期刊>The New England journal of medicine >Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
【24h】

Bundled payment for ESRD--including ESAs in Medicare's dialysis package.

机译:ESRD的捆绑付款-包括Medicare透析包中的ESA。

获取原文
获取原文并翻译 | 示例
           

摘要

In response to a congressional mandate, Medicare has introduced a more constrained method of paying for services covered by its end-stage renal disease (ESRD) program - a method with benefits and risks for patients and providers alike. In the Medicare Improvements for Patients and Providers Act (MIPPA), Congress bundled into a package most of the services provided to dialysis recipients and directed Medicare's administrators to establish a fixed compensation amount for dialysis facilities. This system, which went into effect January 1, trims payments to ESRD facilities by 2% overall and reduces "incentives to overuse profitable, [previously] separately bill-able drugs," particularly erythro-poiesis-stimulating agents (ESAs), because studies showed that such overuse harms patients.
机译:为了响应国会的授权,Medicare推出了一种更为受限的付费方式,以支付其终末期肾脏疾病(ESRD)计划所涵盖的服务-这种方式对患者和医疗服务提供者都具有收益和风险。在《 Medicare改善患者和医疗提供者法案》(MIPPA)中,国会将向透析接受者提供的大多数服务捆绑在一起,并指示Medicare的管理人员为透析设施确定固定的赔偿金额。该系统于1月1日生效,将对ESRD设施的付款总体削减了2%,并减少了“过度使用可获利的,[以前]可单独计费的药物的激励措施”,特别是促红细胞生成刺激剂(ESA),因为研究表明过度使用会伤害患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号